AstraZeneca has changed the name of its coronary vaccine to Vaxzevria, according to an overview of the European Medicines Agency (EMA).
The use of the AstraZeneca vaccine was suspended in several countries in March after several vaccinated people reported cases of blood clots.
The vaccine has been given the green light by both the EU and the WHO.
In Norway, the AstraZeneca vaccination is still on hold.
The name change does not involve any other changes, newspaper Aftonbladet writes.
The Swedish Medicines Agency informed the newspaper that EMA approved the name change on March 25 following an application from the company.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at firstname.lastname@example.org